SOPHiA GENETICS

🚨 24 hours left! Join us for the webinar "Empowering Laboratories with Robust Molecular Analysis: Unlocking MSK-ACCESS®" on July 18, 2024, at 5pm CEST/11am EST - The Pathologist. Discover how MSK-ACCESS® powered with SOPHiA DDM™ enhances precision cancer analysis with a matched tumor-normal approach. Speakers: • Brian Loomis, PhD, Director of Clinical Next-Generation Sequencing, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center • Florian Klemm, MD, PhD, Technical Product Manager, Genomic Research Expert, SOPHiA GENETICS • Verena Schramm, PhD, VP, Product Management, SOPHiA GENETICS 🔗 Register here: https://ter.li/sdu043 #PrecisionOncology #DataDrivenMedicine #Webinar #LiquidBiopsy

📣 ONE DAY LEFT! Don't miss our live webinar at Frontline Genomics "Enhancing variant interpretation: Obtaining answers from a vast universe of data" 🧬 💡Join us for a webinar where we tackle the challenges of pinpointing pathogenic mutations from large, complex datasets. In this webinar, we will demonstrate how variant interpretation with Alamut™ Visual Plus can improve the accuracy and speed of variant interpretation, using specific case studies, such as detecting compound heterozygous variants in Charcot-Marie-Tooth Disease, and Alu insertions in breast cancer. Rolph Pfundt, Clinical Molecular Geneticist at Radboud University Medical Centre in the Netherlands, will share insights into his variant interpretation workflow, highlighting how Alamut™ Visual Plus enables the identification of complex variants with greater ease and precision. Join this insightful exchange and learn how integrating Alamut™ Visual Plus into your NGS workflow can streamline your genomic analysis, making it quicker and easier. ➡️ Book your spot here: https://loom.ly/vAyOX9g Can't attend live? Register today and access the recorded session on-demand at your own convenience!

Don't miss this webinar on Wednesday July 18th at 5pm CEST/11am EST. Brian Loomis, Florian Klemm and Verena Schramm will share a fantastic story about the deployment of the decentralised version of MSK ACCESS. Register now with the link below as a first step towards the future of precision medicine!

A recent WHO study predicts over 35 million new diagnosed cases of cancer by 2050. There is a major need to optimize cancer care to improve outcomes and quality of life. By providing more in-depth information on cancer than ever before, advanced diagnostics could play a critical role in improving outcomes. They can, for example, be used to support earlier and more accurate diagnosis and the selection of highly tailored treatments that are more likely to be effective. We are thrilled to collaborate with industry leaders, alongside The Health Policy Partnership (#HPP), to develop a new report that outlines the policy actions needed to prepare health systems for the future of cancer diagnosis. The report, ‘Powering the future of cancer care with advanced diagnostics’, details the potential for these innovative techniques to transform outcomes for people with cancer, and outlines five priority areas where policymakers can support the widespread adoption of advanced diagnostics. 🔎 Read the report and find out more: https://lnkd.in/dm4RV-GR AstraZeneca | GE HealthCare | Ibex Medical Analytics | The Health Policy Partnership | Thomas Di Maio | Vijay Andani #HealthEquity #DataDrivenMedicine #PrecisionMedicine #AdvancedDiagnostics

📣 Webinar Alert! Don't miss our live webinar at Frontline Genomics this Wednesday "Enhancing variant interpretation: Obtaining answers from a vast universe of data"! 💡Pinpointing pathogenic mutations from large, complex datasets can be difficult, time consuming and somewhat overwhelming. So, how can you streamline your genomic analysis, to make it quicker, easier and more efficient? 🗣️Book your spot now and learn how Alamut™ Visual Plus can help you do this! https://loom.ly/vAyOX9g Can't attend live? Register today and access the recorded session on-demand at your own convenience!

At SOPHiA GENETICS, we're fueled by a powerful mindset: brilliant minds and a culture that empowers them. It's a space where SOPHiANS, like Tom Petty, can bring their authentic selves – their talents, passions, and unique ideas – to the table. Take our company rock band, Background Noise, for example! This brainchild of several SOPHiANS perfectly reflects our mission: cutting through the noise to find the signal that truly matters. While Tom, a true SOPHiAN ambassador, recently embarked on new adventures after 8 incredible years with us, his legacy, along with countless others, lives on. We see it in the stickers proudly displayed on laptops across departments, showing the impact our talented people have on our culture. “We built the band to inspire others and celebrate work and life through music. It has greatly impacted our company culture. Our 8 years of preparation, rehearsals, and performances will always be close to my heart," said Tom. Beyond it, Tom added: “During my tenure here I have been surrounded by extremely smart, creative, caring and passionate people that helped me grow professionally, academically, and even personally. I am most grateful to have achieved so much with this amazing team of SOPHiANS, for the unwavering support from upper management, and for the rich environment that encourages innovation.” We are grateful to all SOPHiANS, past and present, who continue to be ambassadors for our mission while they are with us, as well as long after they leave. 🎸 Here are a few pictures from our annual Kickoff in January 2020, when Background Noise performed – who was there? #CorporateCulture #CompanyCulture #PositiveCulture #Talent

📣 Webinar Alert! Don't miss our next live webinar at Frontline Genomics "Enhancing variant interpretation: Obtaining answers from a vast universe of data"! 💡Pinpointing pathogenic mutations from large, complex datasets can be difficult, time consuming and somewhat overwhelming. So, how can you streamline your genomic analysis, to make it quicker, easier and more efficient? In this webinar you will learn how Alamut™ Visual Plus enables clinical researchers to: ➡️ Resolve splice-site variants using splicing scores and exonic splicing enhancer binding site predictors in a visual interface. ➡️ Conduct familial variant analysis (FVA) for prioritization of germline variants, by excluding those that do not follow Mendelian inheritance patterns. ➡️ Utilize trusted databases, predictors, publications and guidelines, such as the ACMG criteria, for effective genomics interpretation. ➡️ Enhance interpretation through a software that offers comprehensive annotations and visualization of breakpoints and coverage across different file types in a full genome browser. ➡️ Better understand the significance of a guideline-driven approach to variant nomenclature for consistent analysis and reporting. 🗣️Book your spot now! https://loom.ly/vAyOX9g Can't attend live? Register today and access the recorded session on-demand at your own convenience! #genomics #genetics #variantinterpretation #AI #datadrivenmedicine #ML #Alamut #lamutVisualPlus #FrontlineGenomics #webinar

Is your #HRD analysis missing something? Try adding GIInger™. GIInger™ is a cutting-edge, deep learning algorithm that measures genomic instability in ovarian cancer samples using low-pass whole genome sequencing data. Designed to seamlessly integrate with different capture-based workflows, GIInger™ provides a universal approach to genomic instability measurement that complements your BRCA analysis for a complete HRD assessment. 🫚 Ready to add the missing spice to your workflow? Learn more: https://loom.ly/tFdfzzs #DataDrivenMedicine #PrecisionMedicine #CancerResearch #Innovation #Algorithm

Empowering a network of 770+ healthcare institutions worldwide and over 1.7 million genomic analyses to date, SOPHiA GENETICS is dedicated to patient care. Gilles MILLAT, Gilles, a hospital practitioner at Hospices Civils de Lyon - HCL, exemplifies our impact. Traditionally, analyzing Hereditary Cardiac Pathologies was time-consuming. But Dr. Millat has witnessed the transformative power of SOPHiA DDM™, our AI-powered, cloud-native platform. SOPHiA DDM™ streamlines workflows, leading to faster, more accurate analysis. 🤝 Dr. Millat's experience embodies our mission: empowering healthcare professionals globally with cutting-edge solutions. Learn about the SOPHiA DDM™ Platform: https://ter.li/n6kzkf #AIforHealthcare #SOPHiADDM #DataDrivenMedicine #PrecisionMedicine #CardiacDiagnostics

🎬 Webinar alert! Don’t miss the online webinar with North Thames Genomics Laboratory Hub (NTGLH) to understand and discuss the recent changes in ovarian cancer HRD testing on 31 July 2024, 17:00 - 18:30 GMT. 💡 Why attend this webinar? • Testing Changes: Detailed explanation of the changes to HRD testing for advanced ovarian cancer. • Clinical Impact: Insights into what these changes mean for clinicians and their teams, with opportunities for questions and clarifications. • New Reporting System: Overview of the changes to the HRD report and scoring system, including template examples and where to find key information. • Validation and Confidence: Discussion on the validation, comparison of all 4 assays, and review of clinical data from SOPHiA GENETICS. Don’t miss this unique opportunity to engage in an open table discussion around all aspects of the new service, addressing specific requirements in HRD testing for ovarian cancer. 👉 Book your seat here: https://loom.ly/wa9sUv4 #Webinar #OvarianCancer #HRD #Cancer #Roundtable NHS North Thames Genomic Medicine Service